Author Archive for: jennifer-reck
About Jennifer Reck
Jennifer Reck is project director of NASHP’s Center for State Prescription Drug Pricing. The center works with states to develop model policies to address drug prices, tracks legislation and implementation, and provides technical assistance. Since joining NASHP in 2015, she has designed and implemented technical assistance for state learning collaboratives to advance evidence-based policymaking and alternative payment models. She has also directed evaluation teams analyzing delivery system and payment reforms, including State Innovation Models, and led efforts to disseminate findings from a federal initiative to advance evidence-based preventive care.
Prior to joining NASHP in 2015, Jennifer was Maine Medical Association’s (MMA) director of grants management, where she engaged physicians in payment reform as well as outreach and advocacy efforts to implement the Affordable Care Act. She also directed the MMA’s academic detailing program – the Maine Independent Clinical Information Service – an educational outreach program to promote evidence-based primary care. She has also worked as a policy analyst at Prescription Policy Choices, providing states with policy models and technical assistance to address clinical and cost concerns related to prescription drugs, and as a publishing editor at Elsevier Science, managing its portfolio of health policy journals.
She received her master’s degree from Cornell University in Science and Technology Studies and her bachelor’s degree in the history and philosophy of science from Bard College.
Entries by Jennifer Reck
State Drug Price Transparency Programs Identify Critical Data on High Cost Drugs
April 25, 2022 in Policy, Prescription Drug Pricing Maine, Oregon, Washington Blogs, Featured News Home Prescription Drug Pricing /by Johanna Butler and Jennifer ReckStates’ drug price transparency programs are effectively analyzing and reporting data — an important tool for informing the public, holding drug supply chain entities accountable for high costs, and identifying potential policy approaches. Leading states are highlighting high prices for anti-inflammatory drugs, the impact of pharmacy benefit manager (PBM) regulation on drug spending and the […]
Washington Joins Leading States in Establishing a Prescription Drug Affordability Board
April 7, 2022 in Policy, Prescription Drug Pricing Washington Featured News Home Newly-Enacted Laws, Prescription Drug Pricing /by Jennifer ReckOn March 24, 2022, Washington state joined five other leading states in establishing a Prescription Drug Affordability Board (PDAB) when Governor Inslee signed SB 5532, sponsored by Senator Karen Keiser, into law. Washington’s PDAB, like those already established in Maryland and Colorado, has the authority to limit what payers in the state will pay for […]
Drug Price Transparency Laws Position States to Impact Drug Prices
January 10, 2022 in Prescription Drug Pricing California, Maine, Nevada, Oregon, Vermont Blogs, Featured News Home Prescription Drug Pricing /by Johanna Butler and Jennifer ReckDrug price transparency laws enable state policymakers to understand opaque drug pricing and payment systems to formulate appropriate policy solutions to high prices, while also creating the data infrastructure to effectively realize those policy solutions. Since Vermont passed the first state drug price transparency law in 2016, more than a dozen states have enacted and […]
NASHP’s Annual Conference Highlights States Taking Bold Action on Drug Prices
October 20, 2021 in Prescription Drug Pricing Featured News Home Newly-Enacted Laws, Prescription Drug Pricing, State Rx Legislative Action /by Sarah Lanford and Jennifer ReckWhile Congress continues to consider significant reforms for drug pricing, states have taken bold steps to control drug prices across payers. This legislative session, Colorado followed Maryland’s lead and established a prescription drug affordability board (PDAB) to address high drug prices. PDAB legislation, such as Maryland’s and Colorado’s, that includes authority for a board to […]
Sign Up for Our Weekly Newsletter
Sign Up for Our Weekly Newsletter
Washington, DC Office:
1233 20th St., N.W., Suite 303Washington, DC 20036
p: (202) 903-0101
f: (202) 903-2790
Contact Us
Phone: 202-903-0101

For individuals living with complex, often chronic conditions, and their families, palliative care can provide relief from symptoms, improve satisfaction and outcomes, and help address critical mental and spiritual needs during difficult times. Now more than ever, there is growing recognition of the importance of palliative care services for individuals with serious illness, such as advance care planning, pain and symptom management, care coordination, and team-based, multi-disciplinary support. These services can help patients and families cope with the symptoms and stressors of disease, better anticipate and avoid crises, and reduce unnecessary and/or unwanted care. While this model is grounded in evidence that demonstrates improved quality of life, better outcomes, and reduced cost for patients, only a fraction of individuals who could benefit from palliative care receive it. 























































































































































